OMNIgene GUT Dx
Device To Preserve And Stabilize Relative Abundances Of Microbial Nucleic Acids In Clinical Samples
DNA Genotek Inc.
The following data is part of a De Novo classification by Dna Genotek Inc. with the FDA for Omnigene Gut Dx.
Pre-market Notification Details
| DeNovo ID | DEN200040 |
| Device Name: | OMNIgene GUT Dx |
| Classification | Device To Preserve And Stabilize Relative Abundances Of Microbial Nucleic Acids In Clinical Samples |
| Applicant | DNA Genotek Inc. 3000 - 500 Palladium Drive Ottawa, CA K2v 1c2 |
| Contact | Austin Udocor |
| Product Code | QPO |
| CFR Regulation Number | 866.2952 [🔎] |
| Decision | Granted (DENG) |
| 510(k) Premarket Notification | Device Classification Under Section 513(f)(2)(De Novo) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Lin |
| Review Advisory Board | Microbiology |
| Classification Advisory | Microbiology |
| Type | Direct |
| Date Received | 2020-06-15 |
| Decision Date | 2021-11-03 |
| Reclassification Order: | Reclassification Order |
NIH GUDID Devices
| Device Identifier | submissionNumber | Supplement |
| 00627595000774 |
DEN200040 |
000 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.